Orexigen Therapeutics, Inc. finally gained FDA approval for its weight loss drug, Contrave (NB32, naltrexone hydrochloride and bupropion hydrochloride extended-release tablets). We expect investors to react positively to the news. The FDA cleared Contrave as an adjunct to a healthy diet (low on calories) and physical activity for chronic weight management in obese (Body Mass…
Though it is increasingly acknowledged by major business, investors and governments that bitcoin has the power to enable potentially world-changing financial innovations, fundamental issues are still holding back adoption. One of the most prominent, around the world, is the lack of consumer understanding of the subject. For all its development, it remains difficult to explain…
Microsoft Corporation (NASDAQ MSFT) has sent out invites for its September 30 media event. The company will take the wraps off its next-gen Windows 9 Enterprise Technical Preview. The invitation itself has the theme “What’s next for Windows?” Veteran Windows watcher Paul Thurrott said that Windows 8 was even bigger disaster than Windows Vista. Windows…
Now that the iPhone 6 and iPhone 6 Plus are both in the stores and available to Apple fans, people who have purchased this high-profile device will want to get the best out of it. If there is one thing you particularly associate with Apple Inc (NASDAQ AAPL) it is the word apps. So here…
California and especially Los Angeles are known for their car cultures. So it seems logical that a number of companies are looking to test their self-driving cars in the state. Google (NASDAQ GOOG) is one of the few companies who have received a permit for the self driving cars. The California DMV has awarded a…
A new social media billing itself as an online country club launches today at $3000 a year. The new social media, Netropolitan, is primarily billed for the rich. That’s the initiation fee for this elitist social media site that promises to keep you away from the complaints of the 99%. The $3,000 is simply the…
